Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “vaccine”

821 pharma patents match "vaccine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 821
Index total 30,257
Page 23 / 35

Quick answer

This filtered view shows 821 pharmaceutical patents matching "vaccine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

821 results for “vaccine” · 30,257 patents in full index Clear search

  1. US 8367810

    Purified plasmodium and vaccine compositions

    Sanaria Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  2. US 8343499

    Anti-arthropod vector vaccines, methods of selecting and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  3. US 8337860

    Development of dengue virus vaccine components

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  4. US 8337831

    Live, oral vaccine for protection against Shigella dysenteriae serotype 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  5. US 8337832

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  6. US 8337830

    Yeast-based vaccines as immunotherapy

    The Regents of the University of Colorado · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  7. US 8323665

    Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolized ricin

    The Board of Regents of the University of Texas System · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  8. US 8323961

    HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  9. US 8298541

    Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted
  10. US 8298546

    Isolation and purification of P. falciparum merozoite protein-142 vaccine

    The United States of America as represented by the Secretary of the Army · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted
  11. US 8258280

    Plasmodium vivax hybrid circumsporozoite protein and vaccine

    The United States of America as represented by the Secretary of the Army · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  12. US 8258274

    Vaccines containing canine parvovirus genetic variants

    The Board of Regents for Oklahoma State University · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  13. US 8247225

    DNA promoters and anthrax vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  14. US 8227583

    Vaccines containing canine parvovirus genetic variants

    The Board of Regents for Oklahoma State University · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  15. US 8216593

    Parasite vaccine

    The Board of Regents of the University of Texas System · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted
  16. US 8211447

    Recombinant P. falciparum merozoite protein-142 vaccine

    The United States of America as represented by the Secretary of the Army · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  17. US 8211445

    PSM peptides as vaccine targets against methicillin-resistant Staphylococcus

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  18. US 8202520

    Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  19. US 8197823

    Vaccine for porcine reproductive and respiratory syndrome, a preparion method and use thereof

    China Animal Disease Control Center · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  20. US 8187606

    HPV antigen fusion protein vaccine compositions and uses thereof

    Beijing Sunbio Biotech Co. Ltd. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  21. US 8183358

    Puumala virus full-length M segment-based DNA vaccines

    The United States of America as represented by the Secretary of the Army · Granted May 22, 2012 · Expires May 17, 2032

    granted
  22. US 8173362

    Cytomegalovirus surface protein complex for use in vaccines and as a drug target

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted May 8, 2012 · Expires May 3, 2032

    granted
  23. US 8168195

    Vaccines against Escherichia coli O157 infection

    The United States of America, as represented by the Department of Health and Human Services · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  24. US 8168200

    Vaccine against african horse sickness virus

    The Regents of the University of California · Granted May 1, 2012 · Expires Apr 26, 2032

    granted